Key Takeaways Clinical utility is moving from best practice to requirement. The pressure is coming whether or not MolDX goes national. Enhanced CLIA, FDA oversight, and payer policy all point toward a higher bar for evidence.
Need help?
Contact usKey Takeaways Clinical utility is moving from best practice to requirement. The pressure is coming whether or not MolDX goes national. Enhanced CLIA, FDA oversight, and payer policy all point toward a higher bar for evidence.